November 5, 2024
Nilotinib, a drug approved by the US Food and Drug Administration (FDA) to treat chronic myeloid leukemia, improved biomarkers and cognitive outcomes in patients with dementia […]
November 5, 2024
TOPLINE: A survey of around 2000 German women up to 24 months postpartum finds that 66% say they are frustrated with their sex life, whereas only […]
November 5, 2024
TOPLINE: Nearly all patients reported receiving instructions to take levothyroxine (LT4) while fasting, but a third did not adhere to this. Approximately half of patients reported […]
November 5, 2024
Only 12% of the nurses providing patient care at hospitals and health clinics today are men. Although the percentage of nurses has increased — men made […]
November 5, 2024
TOPLINE: Greater exposure to per- and polyfluoroalkyl substances (PFAS) is linked to reduced kidney function in young adults, mediated by changes in the gut microbiome and […]
November 5, 2024
A growing body of research explores the link between stroke risk and regular consumption of coffee, tea, soda, and alcohol. This research roundup reviews the latest […]
November 5, 2024
A new vaccine using mRNA technology protected against first-time and relapsing Clostridioides difficile infection in animal models, according to a press release from the Perelman School […]
November 5, 2024
TOPLINE: Only a small proportion of patients with diabetes have undergone artificial intelligence (AI)–based screening for diabetic retinopathy since 2021, despite approval from the US Food […]
November 5, 2024
Editor’s note: This story has been revised to include additional comments. CHICAGO — In patients with stage IVB anaplastic thyroid cancer, the inclusion of adjuvant pembrolizumab […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623
Next page